Individuals with the following conditions should not take GLP-1 drugs due to health risks: Pancreatitis Endocrine type syndromes Multiple endocrine neoplasia (MEN) Type 2 Thyroid cancer (past or current) GLP-1 drugs are also not approved for use by women who are pregnant, trying to become pregnant or breastfeeding
In fact, I now actually find myself in a better mood than before I took the substance
February 11, 2025 Menopause is inevitable, says Mary Claire Haver, MD
Taking tirzepatide early is unlikely to cause acute medical harm, but it can intensify nausea, vomiting, and gastrointestinal distress by concentrating doses too close together
Semaglutide is currently being investigated in two large phase III clinical trial programs for treating obesity: the STEP program, which aims to obtain regulatory approval for semaglutide as an anti-obesity drug and is evaluating cardiovascular outcomes in 17,500 patients
These brain cells rely on glycolysis in energy generation and produce lactate, which serves as both main energy fuel and a signaling molecule for neurons